PP
PRCT icon

PDT Partners’s Procept Biorobotics PRCT Stock Holding History

PDT Partners’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22,215
Closed -$1.1M – 729
2024
Q1 		$1.1M Hold
22,215
– – 0.1% 318
2023
Q4 		$931K Sell
22,215
-19,337
-47% -$658K 0.1% 300
2023
Q3 		$1.36M Sell
41,552
-9,068
-18% -$309K 0.17% 196
2023
Q2 		$1.79M Buy
50,620
+9,833
+24% +$325K 0.25% 141
2023
Q1 		$1.16M Buy
40,787
+34,690
+569% +$1.22M 0.16% 228
2022
Q4 		$253K Sell
6,097
-132
-2% -$5.67K 0.04% 511
2022
Q3 		$258K Buy
+6,229
New +$248K 0.04% 641

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's PRCT Position: Q2 2024 in Review

PDT Partners sold out of Procept Biorobotics (PRCT) in Q2 2024, closing a stake of 22,215 shares — an estimated $1.1M sold.

PDT Partners first reported a position in PRCT in Q3 2022 and held it in 7 quarters. The position peaked at $1.79M in Q2 2023. 201 funds tracked by Wall St. Rank hold PRCT as of Q2 2024.

  • PDT Partners reported no remaining Procept Biorobotics position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 22,215 Procept Biorobotics shares in Q2 2024, an estimated $1.1M.
  • PDT Partners first reported a position in Procept Biorobotics in Q3 2022 and held it in 7 quarters.
  • PDT Partners's Procept Biorobotics position peaked at $1.79M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.